I believe in providing my patients with a comprehensive family approach to care. Advanced or terminal illnesses can affect all areas of life including personal relationships, work, parenting, emotional and spiritual well being and mental functioning. My goal in providing personalized care is to understand and address the most stressful aspects of the illness for the patient and their family so they may live more consistent with their goals and values.
Here at Ohio State I’m able to collaborate with providers from other fields. This has helped me to integrate psychosocial oncology as a medical specialty. The combination of clinical practice, research and education constantly improves our health care system and the care that we provide to our patients.
In my free time I enjoy exploring local and national parks, reading, art, cooking and writing.
- Director of the OSU Psychosocial Oncology Fellowship
- Developed James Supportive Care Screening used to screen for patient comprehensive care needs and refer to services provided at the OSUCCC - James
- Completed a clinical trial (FOCUS), a psychological intervention for advanced cancer patients to reduce insomnia, worry and uncertainty
- Member of the American Psychosocial Oncology Society Professional Development Committee
Specialties and conditions I treat
- Palliative Medicine
- Sleep Disorders
- Medical Oncology
- Behavioral Medicine
- Chronic Disease
More about my work
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Wells-Di Gregorio has reported no financial relationships with medical device, research and/or drug companies.